全文获取类型
收费全文 | 45744篇 |
免费 | 3897篇 |
国内免费 | 3510篇 |
出版年
2024年 | 108篇 |
2023年 | 575篇 |
2022年 | 1268篇 |
2021年 | 2150篇 |
2020年 | 1443篇 |
2019年 | 1738篇 |
2018年 | 1724篇 |
2017年 | 1246篇 |
2016年 | 1807篇 |
2015年 | 2702篇 |
2014年 | 3234篇 |
2013年 | 3416篇 |
2012年 | 4151篇 |
2011年 | 3716篇 |
2010年 | 2322篇 |
2009年 | 1989篇 |
2008年 | 2311篇 |
2007年 | 2074篇 |
2006年 | 1915篇 |
2005年 | 1547篇 |
2004年 | 1374篇 |
2003年 | 1170篇 |
2002年 | 980篇 |
2001年 | 798篇 |
2000年 | 801篇 |
1999年 | 745篇 |
1998年 | 482篇 |
1997年 | 401篇 |
1996年 | 422篇 |
1995年 | 389篇 |
1994年 | 380篇 |
1993年 | 257篇 |
1992年 | 412篇 |
1991年 | 315篇 |
1990年 | 359篇 |
1989年 | 301篇 |
1988年 | 223篇 |
1987年 | 200篇 |
1986年 | 180篇 |
1985年 | 167篇 |
1984年 | 167篇 |
1983年 | 125篇 |
1982年 | 111篇 |
1981年 | 103篇 |
1980年 | 69篇 |
1979年 | 99篇 |
1978年 | 75篇 |
1977年 | 76篇 |
1975年 | 82篇 |
1973年 | 71篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Lorenzo Dal Bo Paolo Mazzucchelli Antonio Marzo 《Journal of chromatography. B, Analytical technologies in the biomedical and life sciences》2000,749(2):258
Zofenopril is a pro-drug designed to undergo metabolic hydrolysis yielding the active free sulfhydryl compound zofenoprilat, which is an angiotensin converting enzyme (ACE) inhibitor, endowed also with a marked cardioprotective activity. A simple, highly sensitive specific LC–MS–MS method was developed for the determination of zofenopril and zofenoprilat in human plasma. In order to prevent oxidative degradation of zofenoprilat and its internal standard, their free sulfhydryl groups were protected by treatment with N-ethylmaleimide (NEM), which produced the succinimide derivatives. The compounds and their corresponding fluorine derivatives, used as internal standards, were extracted from plasma with toluene. The reconstituted dried extracts were chromatographed and then monitored by a triple-stage-quadrupole instrument operating in the negative ion spray ionization mode. The method was validated over the concentration range of 1–300 ng/ml for zofenopril and 2–600 ng/ml for zofenoprilat. Inter- and intra-assay precision and accuracy of both zofenopril and zofenoprilat were better than 10%. The limit of quantitation was 1 ng/ml with zofenopril and 2 ng/ml with zofenoprilat. Extraction recovery proved to be on average 84.8% with zofenopril and 70.1% with zofenoprilat. Similar recoveries were shown by the above two internal standards. The method was applied to measure plasma concentrations of zofenopril and zofenoprilat in 18 healthy volunteers treated orally with zofenopril calcium salt at the dose of 60 mg. 相似文献
22.
23.
24.
25.
Chen Chen Raymond Dagnino Jr. Charles Q. Huang James R. McCarthy Dimitri E. Grigoriadis 《Bioorganic & medicinal chemistry letters》2001,11(24):3165-3168
Cyclizations of alkylhydrazines with N-acyl-S-methylisothioureas, readily synthesized from acyl chlorides, sodium thioisocyanate, dialkylamines then methyl iodide in a one-pot reaction, gave 1-alkyl-3-dialkylamino-5-phenyltriazoles 7 as major products. The regioisomers were assigned through the use of NOE NMR experiments. While bearing a N-bis(cyclopropyl)methyl-N-propylamino group, this series of compounds shows very good binding affinity on the human CRF1 receptor. Among them, 1-methyl-3-[N-bis(cyclopropyl)methyl-N-propylamino]-5-(2,4-dichlorophenyl)-1H-[1,2,4]triazole 7a had the best binding affinity for the CRF1 receptor (Ki=9 nM). 相似文献
26.
27.
28.
Jian Xiao Dan Chen Xiu-Xian Lin Shi-Fang Peng Mei-Fang Xiao Wei-Hua Huang Yi-Cheng Wang Jing-Bo Peng Wei Zhang Dong-Sheng Ouyang Yao Chen 《PloS one》2016,11(2)
Ginsenoside compound K (CK), a rare ginsenoside originating from Panax Ginseng, has been found to possess unique pharmacological activities specifically as anti-cancers. However, the role of cytochrome P450s (CYPs) in the metabolism of CK is unclear. In this study, we screened the CYPs for the metabolism of CK in vitro using human liver microsomes (HLMs) or human recombinant CYPs. The results showed that CK inhibited the enzyme activities of CYP2C9 and CYP3A4 in the HLMs. The Km and Vmax values of CK were 84.20±21.92 μM and 0.28±0.04 nmol/mg protein/min, respectively, for the HLMs; 34.63±10.48 μM and 0.45±0.05 nmol/nmol P450/min, respectively, for CYP2C9; and 27.03±5.04 μM and 0.68±0.04 nmol/nmol P450/min, respectively, for CYP3A4. The IC50 values were 16.00 μM and 9.83 μM, and Ki values were 14.92 μM and 11.42μM for CYP2C9 and CYP3A4, respectively. Other human CYP isoforms, including CYP1A2, CYP2A6, CYP2D6, CYP2E1, and CYP2C19, showed minimal or no effect on CK metabolism. The results suggested that CK was a substrate and also inhibitors for both CYP2C9 and CYP3A4. Patients using CK in combination with therapeutic drugs that are substrates of CYP2C9 and CYP3A4 for different reasons should be careful, although the inhibiting potency of CK is much poorer than that of enzyme-specific inhibitors. 相似文献
29.
30.
Bing-Ren Huang 《中国科学:生命科学英文版》2010,53(4):531-532
<正>During the Chinese New Year holidays in 2008, Professor Zhang Nai-Heng, former chair of the Department of Biochemistry, Beijing Medical College, informed me of the sad news that Professor Ray Wu had passed away in Ithaca, New York on 相似文献